CML Highlights of ASH 2023 - Biological overview
CML Highlights of ASH 2023 - Clinical overview
iCMLf Conversation: CML Highlights of ASH 2022 - Biological overview
Chronic Myeloid Leukemia -2023 Best of Hematology Conference
iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview
ASH 2021 highlights in CML
Updates in CML: 2023 Best of Hematology
Clonal Hematopoiesis - Presentation Highlights from ASH 2023 with Abhay Singh, MD, MPH
What's Next? Promising Trials and Therapeutics in Myelofibrosis
Updates in CLL - 2023 Best of Hematology Conference
The ALLG CML13 ASCEND-CML study: high major molecular responses with asciminib treatment for CP-CML
The latest advancements in the treatment of Chronic Myeloid Leukaemia (CML) - WEBINAR
ASCEMBL: asciminib versus bosutinib in third-line treatment of CP-CML
iCMLf Conversation: CML Highlights of EHA 2022 - Biological and clinical overview
EHA 2023 CLL highlights
Neue Daten zum Thema CML vom ASH-Kongress 2023
Highlights on myelofibrosis from ASH
Lightning Round Day 2 - 2023 Best of Hematology Conference
Testing for BCR::ABL kinase mutations in CML and how they impact TKi resistance
Ash updates in CML and MPNs